324 related articles for article (PubMed ID: 18494535)
1. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.
Salzman C; Jeste DV; Meyer RE; Cohen-Mansfield J; Cummings J; Grossberg GT; Jarvik L; Kraemer HC; Lebowitz BD; Maslow K; Pollock BG; Raskind M; Schultz SK; Wang P; Zito JM; Zubenko GS
J Clin Psychiatry; 2008 Jun; 69(6):889-98. PubMed ID: 18494535
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
3. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.
Maher AR; Theodore G
J Manag Care Pharm; 2012 Jun; 18(5 Suppl B):S1-20. PubMed ID: 22784311
[TBL] [Abstract][Full Text] [Related]
4. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
5. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
Ballard C; Waite J
Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
7. Risks and benefits of antipsychotic drugs in elderly patients with dementia.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574
[TBL] [Abstract][Full Text] [Related]
8. [Antipsychotics in geriatric institutions].
Szulik J
Vertex; 2007; 18(76):454-60. PubMed ID: 18273435
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
11. Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates.
Marcinkowska M; Śniecikowska J; Fajkis N; Paśko P; Franczyk W; Kołaczkowski M
CNS Drugs; 2020 Mar; 34(3):243-268. PubMed ID: 32052375
[TBL] [Abstract][Full Text] [Related]
12. Risperidone in the management of agitation and aggression associated with psychiatric disorders.
De Deyn PP; Buitelaar J
Eur Psychiatry; 2006 Jan; 21(1):21-8. PubMed ID: 16414250
[TBL] [Abstract][Full Text] [Related]
13. ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia.
Jeste DV; Blazer D; Casey D; Meeks T; Salzman C; Schneider L; Tariot P; Yaffe K
Neuropsychopharmacology; 2008 Apr; 33(5):957-70. PubMed ID: 17637610
[TBL] [Abstract][Full Text] [Related]
14. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
[TBL] [Abstract][Full Text] [Related]
15. Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.
Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
Am J Geriatr Psychiatry; 2007 May; 15(5):416-24. PubMed ID: 17463191
[TBL] [Abstract][Full Text] [Related]
16. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
